Source: Trial Site News


TrialSite hosted the first international Ivermectin for Covid Summit webinar on Sunday, May 23rd 2021. The event was widely attended with medical experts presenting from around the world to a global audience of interested parties in the thousands. The event was simultaneously broadcast live on YouTube.

With a mission to bring transparency and accessibility to clinical research TrialSite continues to track repurposed drugs as a potential option for COVID-19 along with vaccines, novel therapeutics and other measures.


1st International Ivermectin for Covid Summit – Part 1

  • Introduction of speakers
  • Introduction – Dr. Martin Gill (2:00)
  • Welcome – Daniel O’Connor (5:37)
  • Ivermectin use in Zimbabwe – Dr. Jackie Stone (9:20)
  • Introduction to Dr. Sabine Hazan (22:50)
  • Early to treat, early to cure – Dr. Sabine Hazan (26:10)
  • Introduction to Dr. David Scheim (36:45)
  • Ivermectin for COVID-19 treatment in Peru – Dr. David Scheim (37:40)
  • Introduction to Dr. Jennifer Hibberd (50:00)
  • World data – Dr. Jennifer Hibberd (51:00)
  • Introduction to Dr. Lucy Kerr (1:03:00)
  • Ivermectin as a prophylaxis and treatment – Dr. Lucy Kerr (1:05:22)


  • Introduction to Dr. Kylie M. Wagstaff (1:17:30)
  • In-vitro investigations of Ivermectin – Dr. Kylie M. Wagstaff (1:18:30)
  • Introduction to Dr. Tess Lawrie (1:34:25)
  • Sharing evidence on Ivermectin – Dr. Tess Lawrie (1:47:52)
  • Questions to the panel (1:48:20)
  • Closing keynote – Dr. Colleen Aldous

Related: 1st International Ivermectin for Covid Summit – Part 1

Interview with Zimbabwe’s Dr. Jackie Stone: COVID-19 Infection & DEATH RATES PLUMMET Post MCAZ green light for Ivermectin Use

Dr Pierre Kory Talks Ivermectin Success – Benefits Ricochet Around the World

Dr Tess Lawrie’s Powerful Closing Address at the International Ivermectin for Covid Conference​

Ivermectin for Covid-19 evidence update

NIH to Launch Massive ACTIV-6 Phase 3 Clinical Study Investigating Repurposed Drugs & Ivermectin May be on the List

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Stark madness to ban ivermectin

Buried in the note is the real reason for making ivermectin inaccessible – the fear that persons taking it ‘may elect not to be vaccinated as part of the national Covid-19 vaccination program’. This is outrageous. When someone is infected with Covid, it is too late to bother with vaccination. They need early treatment. To deny it to coerce them into accepting a vaccine, one of whose side-effects is death, is immoral.

Read More »

Australia’s TGA Bans GPs from Prescribing Ivermectin

Australia’s medicine and therapeutic regulatory, the Therapeutic Good Administration (TGA) recently took the gloves off with Ivermectin, the economical anti-parasitic drug associated with at least 63 completed clinical trials involving SARS-CoV-2, the virus behind COVID-19. Now TGA formally places a national prohibition on off-label prescribing of ivermectin to all general practitioners. A comparable move as to what TGA did with hydroxychloroquine in 2020. Clearly further evidence of tightening encroachment of the critically important doctor-patient treatment relationship allowing consent to medical treatment using off-label medications. Of course, this isn’t occurring in a vacuum—it’s part of an unfolding, integrated and what have the signs of a coordinated and orchestrated government action to stop any and all treatments other than those the government declares acceptable.

Read More »